Methylobacterium bacteremia after infusion of contaminated autologous bone marrow

Clinical Infectious Diseases

Volumn 23, Issue 5, 1996, Pages 1191-1192

  Brown, Mark A ^b   Greene, John N ^a   Sandin, Ramon L ^b   Hiemenz, John W ^b   Sinnott, John T ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CEFTAZIDIME; EDOBACOMAB; ETOPOSIDE; IFOSFAMIDE; TOBRAMYCIN;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTEREMIA; BACTERIUM CONTAMINATION; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; FEMALE; HUMAN; METHYLOBACTERIUM; NEPHRECTOMY; NEPHROBLASTOMA; PRIORITY JOURNAL;

EID: 0029911040     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.5.1191     Document Type: Article

References (4)

1. Kaye KM, Macone A, Kazanjian PH. Catheter infection caused by Methylobacterium in immunocompromised hosts; report of three cases and review of the literature. Clin Infect Dis 1992;14:1010-4.
2. Brown WJ, Sautter RL, Crist AE. Susceptibility testing of clinical isolates of Methylobacterium species. Antimicrob Agents Chemother 1992;36:1635-8.
3. Lazarus HM, Magalhaes-Silverman M, Fox RM, et al. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant 1991;7:241-6.
4. Wenzel RP, Andriole VT, Bartlett JG, et al. Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis 1992;14:973-6.